Results 101 to 110 of about 1,927 (159)

Short‐Course Raltegravir Intensification Does Not Reduce Persistent Low‐Level Viremia in Patients with HIV‐1 Suppression during Receipt of Combination Antiretroviral Therapy [PDF]

, 2010
Deborah McMahon, Joyce Jones, A. Wiegand, Stephen J. Gange, Mary F. Kearney, Sarah Palmer, S. McNulty, Julia A. Metcalf, Edward P. Acosta, Catherine Rehm, John M. Coffin, John W. Mellors, Frank Maldarelli   +12 more
openalex   +1 more source

Resistance to inhibitors of the human immunodeficiency virus type 1 integration

Brazilian Journal of Infectious Diseases, 2010
This review will summarize the role of integrase in HIV-1 infection, the mechanism of integrase inhibitors and resistance with an emphasis on raltegravir (RAL), the first integrase inhibitor licensed to treat HIV-1 infection.
Daria J. Hazuda, PhD
doaj  

Etravirine–raltegravir, a marked interaction in HIV-1-infected patients: about four cases

, 2009
Amélie Menard, Caroline Solas, Saadia Mokthari, Sylvie Brégigeon, Marie‐Pierre Drogoul, Catherine Tamalet, Bruno Lacarelle, Isabelle Martin   +7 more
openalex   +1 more source

Prevention of HIV Protease Inhibitor-Induced Dysregulation of Hepatic Lipid Metabolism by Raltegravir via Endoplasmic Reticulum Stress Signaling Pathways [PDF]

, 2010
Risheng Cao, Yiqiao Hu, Yun Wang, Emily C. Gurley, Elaine Studer, Xuan Wang, Phillip B. Hylemon, William M. Pandak, Arun J. Sanyal, Luyong Zhang, Huiping Zhou   +10 more
openalex   +1 more source

Sustained Antiretroviral Effect of Raltegravir After 96 Weeks of Combination Therapy in Treatment-Naive Patients With HIV-1 Infection

, 2009
Martin Markowitz, Bach‐Yen Nguyen, Eduardo Gotuzzo, Fernando Mendo, Winai Ratanasuwan, Colin Kovacs, Guillermo Prada, Javier O Morales-Ramirez, Clyde S. Crumpacker, Robin Isaacs, Havilland Campbell, Kim M. Strohmaier, Hong Wan, Robert M. Danovich, Hedy Teppler   +14 more
openalex   +1 more source

Impact of Raltegravir on immune reconstitution and thymopoiesis in HIV‐1‐infected patients with undetectable viremia [PDF]

, 2010
Carmen Garrido, Norma Rallón, Natalia Zahonero, Marisa López, Vincent Soriano, Carmen de Mendoza, José M. Benito   +6 more
openalex   +1 more source

The Effect of Raltegravir Intensification on Low-level Residual Viremia in HIV-Infected Patients on Antiretroviral Therapy: A Randomized Controlled Trial

, 2010
Rajesh T. Gandhi, Lu Zheng, Ronald J. Bosch, Ellen S. Chan, David M. Margolis, Sarah Read, Beatrice Kallungal, Sarah Palmer, Kathy Medvik, Michael M. Lederman, Nadia Alatrakchi, Jeffrey M. Jacobson, Ann Wiegand, Mary F. Kearney, John M. Coffin, John W. Mellors, Joseph J. Eron   +16 more
openalex   +4 more sources

Is Dual Therapy With Raltegravir and Protease Inhibitors a Feasible Option in Rescue Strategy in HIV-1 Infection?

, 2009
Amedeo Capetti, Stefania Piconi, Simona Landonio, Giuliano Rizzardini, Carlo Federico Perno   +4 more
openalex   +1 more source

Use of once‐daily raltegravir‐based HAART in HIV‐infected injection drug users [PDF]

, 2010
HK Tossonian, JD Raffa, O Alenezi, Kevin W. Anderson, Sara Jassemi, K Wight, Stanley DeVlaming, Barbara R. Conway   +7 more
openalex   +1 more source

Informe técnico raltegravir 400mg tableta

, 2011
Basado en la revisión y análisis de la evidencia científica respecto al medicamento Raltegravir 400mg tableta, el Equipo Técnico acuerda no incluirlo al Petitorio Nacional Único de Medicamentos Esenciales (PNUME), debido a que su uso es altamente especializado y es considerado como parte de los esquemas de tercera línea en el manejo de la infección por
openaire   +6 more sources